|
|||||
|
|
The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. |
|
| Authors: | S S Banerji J N Parsons and M J Tocci |
| Institution: | Department of Molecular Immunology, Merck, Sharp and Dohme Research Laboratories, Rahway, New Jersey 07065. |
| Abstract: | |
| Keywords: | |